alexa Abstract | The Paraneoplastic Meaning of R3SPE (Remitting Seronegative Simmetrical Synovitis with Pitting Edema) Syndrome

Journal of Medical Oncology and Therapeutics
Open Access

OMICS International organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations

700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)

Research Article Open Access

Abstract

Introduction: Remitting seronegative symmetrical synovitis with pitting edema (RS3PE) is an uncommon elderly-onset rheumatic disease characterized by tenosynovitis of both flexor and extensors tendons at the wrist and at the feet. Cancer has been reported in association with this syndrome since 1985.

Materials and method: We perform a systematic electronic search of Medline and PubMed for evaluation of relationship between cancer and RS3PE and present in this review the more significant data.

Results: The paraneoplastic weight of RS3PE syndrome is greater than other clinical pictures. In our experience, when RS3PE is associated with polymyalgia rheumatic (PMR), the probability of a paraneoplastic picture is very high (28.5% in our PMR+RS3PE cohort had a cancer diagnosed in an observation time of 24 months vs. 2.04% in cohort of PMR without RS3PE).

Conclusion: The possibility that RS3PE can be considered a paraneoplastic phenomenon or a generic risk factor for cancer is still debated. The repercussions of these evaluations on health policies are easily understandable. More data must be available.

To read the full article Peer-reviewed Article PDF image | Peer-reviewed Full Article image

Author(s): Ciro Manzo

Keywords

RS3PE syndrome, Paraneoplastic syndromes, Elderly, Vascular endothelial growth factor, Oncology, Cancer

 
Peer Reviewed Journals
 
Make the best use of Scientific Research and information from our 700 + peer reviewed, Open Access Journals
International Conferences 2017-18
 
Meet Inspiring Speakers and Experts at our 3000+ Global Annual Meetings

Contact Us

 
© 2008-2017 OMICS International - Open Access Publisher. Best viewed in Mozilla Firefox | Google Chrome | Above IE 7.0 version
adwords